Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study

OBJECTIVES: To prospectively validate that the inability to decrease procalcitonin levels by more than 80% between baseline and day 4 is associated with increased 28-day all-cause mortality in a large sepsis patient population recruited across the United States. DESIGN: Blinded, prospective multicen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Crit Care Med
Autori principali: Schuetz, Philipp, Birkhahn, Robert, Sherwin, Robert, Jones, Alan E., Singer, Adam, Kline, Jeffrey A., Runyon, Michael S., Self, Wesley H., Courtney, D. Mark, Nowak, Richard M., Gaieski, David F., Ebmeyer, Stefan, Johannes, Sascha, Wiemer, Jan C., Schwabe, Andrej, Shapiro, Nathan I.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2017
Soggetti:
Feature Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389588/
https://ncbi.nlm.nih.gov/pubmed/28257335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCM.0000000000002321
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi